Skip to main content

887 publications

Name Date Type Actions

Buyback programs - November 2024

Monthly communication regarding buyback programs 

Liquidity contract , Description of buyback programs

Monthly information regarding the total number of voting rights – November 2024


As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Voting rights

Monthly information regarding the total number of voting rights – October 2024


As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Voting rights

Buyback programs - October 2024

Monthly communication regarding buyback programs 

Liquidity contract , Description of buyback programs

Sales at end September 2024

At the end of September 2024, Vetoquinol sales totaled €398 million, up +1.6% on a reported basis and +1.8% at constant exchange rates.

Public releases

Buyback programs - September 2024

Monthly communication regarding buyback programs 

Description of buyback programs

Monthly information regarding the total number of voting rights – September 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

2024 half-year Results

Sales: €264m (+3.2% as reported)
Essentials products sales: €160m (+6.0% of Group sales)
Net income - Group share: €24m (9.0% of sales)
EBITDA*: €45m (17% of sales)
Cash-flow generation: €27m

Public releases

2024 Half-Year Results slideshow

Contents
1. First semester 2024 results
2. Conclusion and outlook

Half Year Report

Rapport financier semestriel 2024 (French)

Rapport financier semestriel 2024 (French)

Half Year Report